Longevity Investors Conference

Two features. One conversation the longevity industry can't avoid.

Moneycab has published an in-depth interview with our CEO, Lucia Kupcova, alongside a look at the LIC 2026 programme, from why measurement and diagnostics may lead the institutional money, to the year-round community taking shape beyond Gstaad.
As Lucia puts it: "Our mission at Longevity Investors is to connect the people shaping the future of human health and longevity, investors, entrepreneurs, scientists, family offices, and industry leaders."

Both are live now. Read the features: https://www.longevityinvestors.ch/

The debates, the experiences, and the introductions you won't find anywhere else, with candid dialogue and exceptional company.

The $500M Question, with Dr. Steve Horvath, Dr. Collin Y. Ewald, and Prof. Dr. Evelyne Yehudit Bischof, MD, MPH.

The 100-Year Blueprint, with Dr. Aubrey de Grey, Natalie Coles, and Dr. Tobias Reichmuth.

From Science Fiction to Science Fact, with Jonathan Anomaly, Prof. Dr. Michael Levin, and Alice Gilman.

And many more.
Movement with THE UNIT, woven through the days: an alpine journey, a morning run, breathwork and recovery. A gala with its glamour, into the grand finale. Longevity lived, not just discussed.
Roundtables led by our expert speakers, diving into the key topics shaping the future of longevity. A chance to engage directly, ask questions, and exchange insights in an informal setting.
Only a glimpse for now. More to come.

Learn more: 🎟️ https://www.longevityinvestors.ch/lic-2026

This year, longevity stopped being a someday story.

Life Biosciences dosed the first human in a cellular reprogramming trial. NewLimit raised $435 million. Insilico went public with Eli Lilly and Tencent backing it. Retro, funded by Sam Altman, moved toward the clinic.

And at the edges: embryo-editing startups, a gray market with real risks, and cryonics turned real business, with Tomorrow.Bio now holding over €160 million in contracts.

Our new read on the year the moonshots became investable: www.longevityinvestorsnews.ch/post/longevity-moonshots-2026